Pilot Study Assessing Computerized Cognitive Behavioral Therapy for Depression
1 other identifier
interventional
128
1 country
1
Brief Summary
Standard treatments for depression in specialty care settings are effective but resources for delivering empirically supported psychotherapies are often limited. Computerized cognitive behavioral therapy (cCBT) is an effective and highly scalable treatment for depression that might help expand services in psychiatric settings, however, little is known about its efficacy in this population. The present study aims to establish the efficacy of a internet-delivered cCBT program ("Beating the Blues") plus email and telephone support for depression in a psychiatric outpatient clinic setting. The secondary aim is to pilot an assessment procedure designed to identify moderators of treatment effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable major-depressive-disorder
Started Apr 2014
Typical duration for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 28, 2013
CompletedFirst Posted
Study publicly available on registry
November 21, 2013
CompletedStudy Start
First participant enrolled
April 14, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedMarch 24, 2023
March 1, 2023
2.1 years
October 28, 2013
March 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Hamilton Rating Scale for Depression (HRSD) from 0 to 8 weeks
The 17-item HRSD, modified to assess atypical symptoms, is a standard interview-administered measure of depressive symptom severity. The HRSD will be administered by study personnel supervised by the Principal Investigator.
week 0, week 8
Secondary Outcomes (1)
Change in Patient Health Questionnaire-9 (PHQ9) over 8 weeks
weeks 0-8
Other Outcomes (2)
Change in Generalized Anxiety Disorder-7 (GAD7) over 8 weeks
weeks 0-8
Change in Depression Anxiety and Stress Scale-21 (DASS21) over 8 weeks
week 0, week 8
Study Arms (2)
Beating the Blues
EXPERIMENTALBeating the Blues plus helper support.
Waitlist Condition
NO INTERVENTIONEight week waitlist condition group parallel to the immediate treatment condition with optional entrance into the Beating the Blues after the first eight weeks
Interventions
The BtB program guides patients through a series of 8 fully automated online lessons intended to help them identify and change problematic patterns of thinking and behavior that maintain depression. Support will be provided by licensed professional therapists over the phone or via email.
Eligibility Criteria
You may qualify if:
- Diagnosis of Major Depressive Disorder (MDD) according to Diagnostic and Statistical Manual Fourth Edition criteria
- Able and willing to give informed consent
- Have access to a computer with an internet connection at home
You may not qualify if:
- History of bipolar affective disorder or psychosis
- Current Axis I disorder other than MDD if it constitutes the predominate aspect of the clinical presentation and if it requires treatment other than that being offered
- History of substance dependence in the past six months
- Subnormal intellectual potential (IQ below 80)
- Clear indication of secondary gain (e.g., court ordered treatment or compensation issues)
- Current suicide risk or significant intentional self-harm in the last six months sufficient to preclude treatment on an outpatient basis
- Discharge within six moths from a higher level of care (inpatient, partial hospital, or intensive outpatient treatment)
- Currently undergoing outpatient psychotherapy
- Current antidepressant medication treatment if the individual has had a change in medication over the past month or is planning a change in medication during the duration of the study
- Inability to read and write English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel R Strunk, PhD
Ohio State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 28, 2013
First Posted
November 21, 2013
Study Start
April 14, 2014
Primary Completion
May 3, 2016
Study Completion
May 1, 2017
Last Updated
March 24, 2023
Record last verified: 2023-03